Doug Hampton 
– Menarini Group comparte un nuevo análisis del estudio clínico EMERALD de ORSERDU® (Elacestrant) en cáncer de mama metastásico en ASCO 2023 ORSERDU (elacestrant) fue aprobado por la FDA en enero de 2023 para el cáncer de mama avanzado o metastásico con receptor de estrógeno (ER) positivo, receptor 2 del factor de crecimiento epidérmico humano … Read more
TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has … Read more
The global urinalysis market is expected to grow primarily due to the expansion of the healthcare system. Disease screening sub-segment is expected to flourish immensely. The market in the North America region is predicted to grow at a high CAGR by 2031. NEW YORK, May 29, 2023 /PRNewswire/ — Global Urinalysis Market Forecast Analysis: As … Read more
LONDON , May 29, 2023 /PRNewswire/ — Lung cancer has emerged as one of the most commonly occurring ailments across the globe. This deadly disease has a high number of mortality rates. Patients affected with this disease experience difficulties in breathing, cough, chest pain, and other severe symptoms due to the inability of lungs to supply … Read more
HMBD-002, a non-depleting, high-affinity anti-VISTA antibody, possesses key design features enabling robust anti-tumor activity in preclinical models, positioning it as a potentially important new therapy for VISTA-expressing cancers including triple-negative breast cancer and non-small cell lung cancer HMBD-002 is currently being assessed in a Phase 1 study to determine the recommended Phase 2 dose as … Read more
HIGHLIGHTS Amplia’s highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic cancer FOLFIRINOX is the most widely used treatment for pancreatic cancer patients in the US, Canada and most European countries This new data supports clinical studies investigating the combination of AMP945 in a second … Read more
PISA, Italy, May 29, 2023 /PRNewswire/ — Abiogen Pharma S.p.A., Italian leading company in the field of osteoarticular and bone metabolism diseases, is pleased to announce the acquisition of a 97,09% stake in EffRx Pharmaceuticals SA, a Swiss company that develops and markets prescription drugs targeted in particular to musculoskeletal and rare pathologies on European … Read more
(ETX Daily Up) – How to be more successful on dating sites? Singles would have found a trick: display their financial situation. If she is comfortable, then they would attract more partners. On the Hinge dating app, a new trick has emerged lately, that of displaying your credit score. The latter is supposed to represent … Read more
the essential The maternity hospital of Péronne in the Somme suspends its deliveries throughout the month of June due to a lack of anesthetist over the period. The lack of resources in hospitals can have harmful effects on the lives of the French… We can discover this with the specific case of future mothers who … Read more
PISE, Italie, 29 mai 2023 /PRNewswire/ — Abiogen Pharma S.p.A., société italienne leader dans le domaine des maladies ostéo-articulaires et du métabolisme osseux, a le plaisir d’annoncer l’acquisition d’une participation de 97,09 % dans EffRx Pharmaceuticals SA, une société suisse qui développe et commercialise des médicaments sur ordonnance ciblant en particulier les pathologies musculo-squelettiques et rares … Read more